In our analysis, we identified two target gene clusters of biochanin A including inflammatory genes (IL1A, IL2, and IL6R) and cell proliferation genes (CCND1, PPARG, and EGFR) relevant to the treatment of CRC/COVID-19. The gene discussed is IL1A; the disease is COVID-19.